物质信息

ID:348264

名称和标识
IUPAC标准名
N-(2,6-dichlorophenyl)-N-(prop-2-en-1-yl)-4,5-dihydro-1H-imidazol-2-amine
IUPAC传统名
alinidine
别名
ST-567N-(2,6-Dichlorophenyl)-4,5-dihydro-N-2-propenyl-1H-imidazol-2-amineAlinidine
数据登录号
PubChem SID
化合物性质
产品相关信息
纯度
≥98% (HPLC)
Empirical Formula (Hill Notation)
C12H13Cl2N3
安全信息
GHS危险声明
H301-H315-H319-H335
个人保护装置
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
GHS危险品标识
GHS06
急性毒性(口服,皮肤接触,吸入),类别1,2,3
GHS警示性声明
P261-P301+P310-P305+P351+P338
保存条件
under inert gas
保存温度
2-8°C
RTECS编号
NJ1552500
安全公开号
26
GHS警示词
Danger
欧盟危险性物质标志
有害性 有害性 (Xn)
MSDS下载
危险公开号
22-36/37/38
德国WGK号
3
理化性质
外观
off-white solid
溶解度
DMSO: >10 mg/mL
描述信息
Caution
Air-sensitive
Biochem/physiol Actions
Alinidine is an HCN Channel blocker of neuronal Ih, related cardiac If channels and ATP-sensitive Kir channels. It is an analog of clonidine; bradycardic and antiarrhythmic agent (sinus tachyarrhythmias). Alinidine affects physiological markers in conscious dogs. Alinidine in four intravenous (i.v.) injections of 0.5, 0.5, 1, and 2 mg/kg, decreased sinus rate (< or = 43%) and ventricular rate (< or = 44%), but increased atrial rate (< or = 31%). It lengthened CSRT (< or = 71%) at the two highest doses and increased AERP (< or = 33%) and decreased WP (< or = 33%) at all doses. Alinidine did not modify mean blood pressure at any dose in either group. These results indicate that alinidine exhibits electrophysiologic effects in conscious dogs that reflect the marked antiarrhythmic potential of this agent, apart from its assumed antiischemic properties.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据